25-NSE ·Filed Apr 8, 2026

AZN

ASTRAZENECA PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0000876661-26-000343
Notable filing: 25-NSE
Actionable Insight • Neutral

No trading or investment action is required; this is a standard post-maturity administrative step. Investors should note that AstraZeneca has fulfilled its obligation on this debt issue, reducing future interest expense.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
AZN ▼ -4.41% at T+60d
NEUTRAL call ✗ call lost -4.41% · α vs SPY -14.58% · entry $204.16 → $195.15
Entry anchored
Apr 8, 02:20 PM ET
via exchange tick
T+1d
+0.37%
call +0.37% · α -0.21%
$204.91
settled 6mo ago
T+5d
-1.55%
call -1.55% · α -5.06%
$201.00
settled 6mo ago
T+20d
-11.23%
call -11.23% · α -19.77%
$181.24
settled 5mo ago
T+60d
-4.41%
call -4.41% · α -14.58%
$195.15
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

AstraZeneca PLC's 0.700% Notes due 2026 were redeemed at maturity on April 8, 2026, prompting the New York Stock Exchange to notify the SEC of the removal of the related securities from listing and registration. This is a routine administrative action following the maturity of debt obligations.

Key Facts

  • The 0.700% Notes due 2026 were redeemed at maturity on April 8, 2026.
  • NYSE filed Form 25-NSE to remove the guarantor of these notes from listing and registration.
  • Trading in the security was suspended on April 8, 2026.
  • This action is pursuant to SEC Rule 12d2-2(a)(2), which allows for delisting of matured or retired securities.

Financial Impact

Redemption of notes at maturity — no additional financial impact beyond normal debt repayment.

debtinterest expense

Risk Factors

  • None material — this is a routine redemption of matured debt.
  • Minimal operational risk as the delisting follows contractual maturity.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0000876661-26-000343
Document: 0000876661-26-000343-index.html0000876661-26-000343
Document: 0000876661-26-000343.txt0000876661-26-000343
54 reports for AZN
Performance horizon
67% Hit rate 20 of 30 directional calls best @ T+60▲ +13.65%Jul 6, 2026
Filters
Rows
Reports for AZN — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
6-K
NEUTRAL ★ 2/10
$161.85 $168.37▲ +4.03%▲ +1.90%$156.97 (−3.02%)
Sep 14, 2026
18d ago
6-K
BEARISH ★ 5/10
$163.78 $168.10▼ −2.64%▼ −2.53%$156.97 (+4.16%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 7/10
$160.04 $161.85▲ +1.13%▲ +2.25%$156.97 (−1.92%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$162.22 $156.94▼ −3.25%▼ −3.33%$156.97 (−3.23%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$162.22 $156.94▼ −3.25%▼ −3.33%$156.97 (−3.23%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$162.47 $156.94▼ −3.40%▼ −3.49%$156.97 (−3.39%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 7/10
$162.22 $156.94▼ −3.25%▼ −3.33%$156.97 (−3.23%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 5/10
$162.22 $156.94▼ −3.25%▼ −3.33%$156.97 (−3.23%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 7/10
$162.47 $156.94▼ −3.40%▼ −3.49%$156.97 (−3.39%)
Aug 31, 2026
4w ago
Court Ruling
BEARISH ★ 3/10
$162.13 $159.95▲ +1.34%▲ +1.20%$156.97 (+3.18%)
Showing 10 of 54

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access